ABILEAP Trademark

Antibody products and molecules, namely, antibody reagents used for the detection of antigens in cells and tissue for scientific purposes; antibody products and molecules, namely, antibodies acting as immune modulators for scientific purposes

Antibody products and molecules, namely, antibodies acting as immune modulators for medical purposes; colostral antibodies for medical purposes; pharmaceutical antibodies for medical use in the treatment of hereditary angioedema (HAE); pharmaceutical antibodies for medical use in the treatment of respiratory diseases and respiratory syndromes; pharmaceutical antibody preparations for the treatment of auto-immune diseases; pharmaceutical antibody preparations for the prevention and treatment of auto-immune diseases; pharmaceutical antibody preparations for the treatment of cancer; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories; antibody products, namely, antibody reagents used for the detection of antigens in cells and tissue, for medical purposes

Antibody profiling for scientific research purposes and for discovery and development of new biotherapeutics; providing an online scientific database and website featuring information about medical and scientific research in the fields of cancer, immunology, inflammation, biologics, antibodies and molecules; molecule development, namely, pharmaceutical drug development services; scientific research in the field of conducting clinical trials for others; providing temporary use of a non-downloadable software for managing information in the fields of cancer, immunology, inflammation, biologics, antibodies and molecules; Platform as a service (PAAS) featuring a computer software platform for analyzing molecular and clinical data to develop antibodies against immune targets; chemical analysis in the field of molecular biology; biotherapeutic research services, namely, molecular analysis and product optimization for the purpose of pharmaceutical development